Position in MDGL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$264,179
+$6,632 QoQ
Shares Held
492
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#298
of 411 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $50,552,262 across 50 Biotechnology names. MDGL ranks #31 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,129 | $13,798,316 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
146,259 | $5,705,563 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
15,400 | $2,884,112 | |
| 4 | TYRA |
Tyra Biosciences, Inc.
|
83,783 | $2,676,029 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,250 | $2,111,102 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
99,771 | $1,860,729 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
75,714 | $1,823,193 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
107,453 | $1,818,104 |
All Filings in MDGL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $264,179 | 492 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $257,547 | 492 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $228,277 | 392 | Shares | Sole | 2026-02-02 | |
| 2024-06-30 | $367,009 | 1,310 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $325,788 | 1,220 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||